Recombinant Human SLC30A3 Protein，His

SLC30A3, a member of the solute carrier family, encodes a zinc transporter that plays a pivotal role in the cellular regulation of zinc homeostasis. Dysregulation of zinc transport is implicated in various physiological and pathological processes, including neurodegenerative diseases, metabolic disorders, and cancer. While much attention has been given to other members of the SLC30 family, SLC30A3 has not been as extensively studied, highlighting a crucial gap in our understanding of zinc biology. Recent research indicates that SLC30A3 is predominantly expressed in the brain and testis, suggesting a specialized function in these tissues. Moreover, its downregulation has been associated with conditions such as impaired neurogenesis and fertility issues. Consequently, there is increasing interest in the recombinant production of SLC30A3 to investigate its structure, function, and interactions at the molecular level. By producing SLC30A3 as a recombinant protein, researchers aim to elucidate its role as a zinc transporter, assess its impact on zinc-dependent signaling pathways, and explore its potential as a therapeutic target for diseases linked to zinc deficiency or dysregulation. Understanding the biochemical properties and interactions of SLC30A3 through recombinant technology may pave the way for novel strategies in treating conditions related to zinc imbalance, ultimately contributing to the field of cellular biochemistry and therapeutic development.